Navigation Links
Children's Hospital Oakland is first pediatric hospital to use 'laboratory-on-a-card' technology
Date:4/23/2009

April 20, 2009-Oakland, Calif.- Children's Hospital & Research Center Oakland is the first children's hospital in the country to use groundbreaking technology that could revolutionize the way blood is analyzed at pediatric hospitals. This new method uses smart-card technology, similar to that used in some debit or credit cards at the supermarket or gas station, to read a child's blood sample.

The procedure starts with a respiratory therapist who takes a tiny finger stick sample of patient blood at bedside and places it on the diagnostic card. The card is slipped into a handheld wireless card reader or "host mobile computer" and blood gases are immediately analyzed. The respiratory therapist, along with the medical team, can quickly adjust the child's ventilator or other life support device settings, based on the nearly instantaneous measurements.

"What it's allowed us to do is be more efficient, effective and safe," said Katie Sabato, RRT, MS, director of respiratory care at Children's Hospital. She and her colleagues are convinced the new system could become an iPhone-like success story. What used to take 30 minutes to analyze and report, now takes 3 minutes.

Respiratory therapists at Children's Hospital Oakland do about 20,000 point-of-care blood gas and electrolyte measurements a year. "We are always interested in being in the forefront of making the best technology available for children," said Vivienne Newman, MD, clinical director of the Pediatric Intensive Care Unit and a veteran Children's Hospital intensivist. "We're always looking to see if there's new technology that will make running the ICU more efficient and more child-friendly, allow us to minimize discomfort and maximize our results, and make measurement as accurate as possible, while ensuring patient safety."

Children's Hospital Oakland collaborated with Epocal, the Canadian-based biomedical device manufacturer, to successfully modify and fine-tune the equ
'/>"/>

Contact: Diana Yee
dyee@mail.cho.org
510-428-3120
Children's Hospital & Research Center at Oakland
Source:Eurekalert

Page: 1 2

Related biology news :

1. Research could lead to new non-antibiotic drugs to counter hospital infections
2. Mount Sinai Hospital researcher makes stem cell breakthrough
3. International copper industry defines role in the fight against hospital infections
4. Childrens Hospital scientists achieve repair of injured heart muscle in lab tests of stem cells
5. Rhode Island Hospital simulation center examines benefits and applications of medical simulation
6. First results from hospital trials testing
7. Field-hospital-on-a-chip project awarded to nanoengineer from UC San Diego
8. Brown University and Women & Infants Hospital expand national childrens study to Bristol County
9. Childrens Hospital researchers identify genetic mutation that may predict organ rejection
10. Rhode Island Hospital study finds link between obesity, type 2 diabetes and neurodegeneration
11. Childrens Memorial Hospital of Chicago receives a grant from BioMarin to support adult PKU outreach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2015)... and TELTOW, Germany , August 10, ... (SMI), a world leader in Eye Tracking Technology for ... its OEM Eye Tracking Platform for integration into all ... contains reference designs for seamless integration of eye tracking ... reality HMDs and augmented reality smart glasses. Omnivision,s leading ...
(Date:8/6/2015)... TELTOW, Germany , August 6, 2015 ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted ... this new solution, unprecedented quality and efficiency is brought ... context-sensitive displays. For the first time, professionals and researchers ...
(Date:8/5/2015)... , August 5, 2015 ... titled "Facial Recognition Market - Global Industry Analysis, Size, ... global market for facial recognition is forecast to reach ... by increased demand for surveillance systems by civil and ... number of crimes and terrorist activities across the globe ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6
... University of California, Berkeley, scholar and Italian experts are at ... paintings or the art of ancient glassblowers. Instead, the team ... of fungi in Italy to create an unprecedented DNA database. ... - many of which are quite rare - are housed ...
... protein "transit system" may lie at the heart of ... , In the Sept. 17 online issue of Nature ... of a mutation that causes severe skeletal deformities in ... , The findings are surprising, said Ela Knapik, ...
... researchers at the University of Alberta in Edmonton, Canada have ... an ancient mammal that still defies classification. , The findings, ... and only comprehensive account of the creature, named Horolodectes sunae, ... Horolodectes lived about 60 million years ago, soon after the ...
Cached Biology News:Researchers barcode DNA of Venice museum's vast fungi collection 2Researchers barcode DNA of Venice museum's vast fungi collection 3Researchers barcode DNA of Venice museum's vast fungi collection 4Cellular traffic backups implicated in skeletal malformations 2Cellular traffic backups implicated in skeletal malformations 3Researchers give name to ancient mystery creature 2
(Date:8/26/2015)... VANCOUVER , Aug. 26, 2015 /PRNewswire/ - iCo ... ICOTF), today reported financial results for the quarter ... are expressed in Canadian dollars and presented under ... continue pre-clinical activities with respect to our Oral ... of a contract manufacturer," said Andrew Rae ...
(Date:8/26/2015)... , Aug. 26, 2015  The Diabetes ... the University of Miami Miller School of Medicine, ... clinical trial to test for the first time ... successfully completed.  This FDA approved Phase I/II study ... transplantation and is an important first step toward ...
(Date:8/26/2015)... BEIJING , August 26, 2015 ... DiaCardio wins 1 st place  Wayerz ... led in Israel by venture capital fund ... countries including the US, China , ... Latin America .  Impressive achievement for the Israeli ...
(Date:8/26/2015)... 26, 2015 Despite recent ... the optimism in biotech,s forecast is the recent ... sciences advancements.  Active biotechnology & healthcare companies with ... (OTCQB: PBIO), Sequenom, Inc. (NASDAQ: SQNM ), ... Pharmaceutical Corp. (NASDAQ: RPTP ) and EnteroMedics ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
... CHICAGO, Jan. 4, 2011 Advanced Life Sciences ... ), a biopharmaceutical company engaged in the discovery, development ... of infection, oncology and respiratory diseases, today announced that ... Healthcare Conference held January 10-12th in San Francisco. ...
... LANSING, Mich., Jan. 4, 2011 Neogen Corporation (Nasdaq: ... the second quarter of FY 2011, which ended Nov. 30, ... in the quarter rose to $6,110,000, or $0.26 per share, ... revenues increased 25% to $43,931,000, compared to the prior year,s ...
... Vaccinex, Inc. announced today that it has received clearance ... trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics ... advanced solid tumors. (Logo: http://photos.prnewswire.com/prnh/20101101/NY92716LOGO ) ... blocks the activity of semaphorin 4D (SEMA4D).  It is ...
Cached Biology Technology:Advanced Life Sciences to Present at the Biotech Showcase™ 2011 Conference 2Neogen Reports 33% Increase in Net Income 2Neogen Reports 33% Increase in Net Income 3Neogen Reports 33% Increase in Net Income 4Neogen Reports 33% Increase in Net Income 5Vaccinex, Inc. Initiates Clinical Trial of Novel Therapeutic Antibody in Cancer Patients With Advanced Solid Tumors 2
Rat monoclonal to UGGT ( Abpromise for all tested applications)....
Mouse monoclonal [15-2] to Mannose Receptor (Biotin) ( Abpromise for all tested applications). entrezGeneID: 4360 SwissProtID: P22897...
Request Info...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Biology Products: